Home Trending Stocks Adverum Biotechnologies Inc. (ADVM) stock declined in the premarket trading session; here’s...

Adverum Biotechnologies Inc. (ADVM) stock declined in the premarket trading session; here’s why

In the premarket trading session, Adverum Biotechnologies Inc. (ADVM) stock plunged by -52.66% to the price of $4.81 at the time of writing. ADVM stock previously closed the session at $10.16 gaining 3.04%. The ADVM stock volume traded about 2.9 million shares. While the average trade volume for the past 3 months has been 806.18K shares. In the past year, ADVM stock plunged by -16.45%. However, in the past week, the shares rallied up by 10.20%. In the past three and six months, the ADVM stock shed-16.45% and -14.48%. Adverum Biotechnologies, Inc. is currently valued at $1.00 billion and has 97.60 million outstanding shares.

Get the hottest stocks to trade every day before the market opens 100% ‎free. Click here now. 

Adverum Biotechnologies, Inc.’s operational background

Adverum Biotechnologies, Inc., a clinical-stage gene therapy company that focuses on developing treatments for rare diseases. Adverum Biotechnologies, Inc. was previously known as Avalanche Biotechnologies, Inc. and changed its name to the current one in May 2016. The headquarter of the company is in Redwood City, California. The treatments are gene therapy candidates used for ocular diseases. The company’s leading product is the ADVM-022 candidate. ADVM is a single-dose injection that is intravitreal-administered. This gene therapy focuses on the treatment of chronic retinal diseases of the patients and also treats wet age-related macular degeneration as well as diabetic macular edema.

5 Stocks Under $10 That Are Poised to Take Off

Investing in stocks under $10 could significantly increase the returns on your portfolio, especially if you pick the right stocks! Within this report you will find 5 top stocks that offer investors huge upside potential and the best bang for their buck.

Add them to your watchlist before they take off!

Get the Top 5 Stocks Now!

Sponsored

Read More

Adverum Biotechnologies has collaborated along with academic institutions like Cornell University and the University of California as well as licensing agreements with companies which include GenSight, Lexeo, and Virovek.

Announcement of SUSAR occurring in one ADVM-022 trial patient

On 28th April 2021, the clinical gene therapy company which focuses on ocular disease treatment- Adverum Biotechnologies, Inc. has announced that it has faced the occurrence of SUSAR of hypotony in one of its trials. SUSAR means a Suspected Unexpected Serious Adverse Reaction of hypotony which occurred specifically in ADVM-022 for its clinical trial INFINITY in order to treat diabetic macular edema.

The event occurred in one patient who was treated with a single intravitreal high dose of ADVM-022. This happened after a 30 weeks’ randomization and caused a hypotony development and caused loss of vision in the treated eye as well as panuveitis.

ADVM stock has decided that it is in the interest of all parties to investigate the INFINITY phase 2 study in order to examine the causes and potential risk problems that occurred in the development of ADVM-022. This will help understand why the SUSAR occurred and how to prevent this from occurring in other patients in this study, which completed the patient dosing in December last year. The investigational data gathered from the ADVM-022 program by the Adverum’s Data Monitoring Center (DMC) is then expected by the company to report in the future along with the progression of analysis.

Get the hottest stocks to trade every day before the market opens 100% ‎free. Click here now. 

How will the overall evaluation proceed?

This evaluation process will entail the monitoring of all the patients and the study further sites to proactively create additional recommendations about how the patients in the future should be monitored with additional managing. Furthermore, Adverum has taken the necessary step to notify the FDA and all clinical trial sites.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Must Read

Biocept Inc. (BIOC) stock surged during current market trading. Why is it so?

Biocept Inc. (NASDAQ: BIOC) stock gained by 3.13% in the current market trading. Biocept creates and sells molecular diagnostic tests that offer doctors with...

Comstock Mining Inc. (LODE) stock soar during pre-market trading. What’s happening?

Comstock Mining Inc. (NASDAQ: LODE) stock gained by 1.14% at last close while the LODE stock price surged by 3.10% in the pre-market trading...

Why MediciNova Inc (MNOV) stock facing negativity since Monday’s after-hours?

MediciNova Inc. (MNOV) shares lost 5.71% in after-hours on Monday, June 21, 2021, and the plummeting continues in the pre-market session on Tuesday as...

Here is why Sanderson Farms Inc. (SAFM) stock rallied on Monday?

Sanderson Farms Inc. (SAFM) shares surged 10.16% in after-hours on Monday, June 21, 2021, and close the day at $183.50 per share. Earlier in...

Torchlight Energy Resources Inc. (TRCH) stock surged during current market trading. Here’s to know why?

Torchlight Energy Resources Inc. (NASDAQ: TRCH) stock gained by 41.33% in the current market trading session. Torchlight Energy Resources is a vast growing oil...

Bio-Path Holdings Inc. (BPTH) stock gains during current market trading. Here’s to know why?

Bio-Path Holdings Inc. (NASDAQ: BPTH) stock surged by 8.76% in the current market trading. Bio-Path is a biotech firm working on DNAbilize, a new...

Comstock Mining Inc. (LODE) stock soar during pre-market trading. What’s happening?

Comstock Mining Inc. (NASDAQ: LODE) stock gained by 1.14% at last close while the LODE stock price surged by 3.10% in the pre-market trading...

Vinco Ventures, Inc. (BBIG) stock surged during pre-market trading, given no recent news.

Vinco Ventures, Inc. (NASDAQ: BBIG) stock gained by 11.75% at last close whereas the BBIG surged by 7.38% in the pre-market trading. Vinco Ventures...

Related News

Biocept Inc. (BIOC) stock surged during current market trading. Why is it so?

Biocept Inc. (NASDAQ: BIOC) stock gained by 3.13% in the current market trading. Biocept creates and sells molecular diagnostic tests that offer doctors with...

Comstock Mining Inc. (LODE) stock soar during pre-market trading. What’s happening?

Comstock Mining Inc. (NASDAQ: LODE) stock gained by 1.14% at last close while the LODE stock price surged by 3.10% in the pre-market trading...

Why MediciNova Inc (MNOV) stock facing negativity since Monday’s after-hours?

MediciNova Inc. (MNOV) shares lost 5.71% in after-hours on Monday, June 21, 2021, and the plummeting continues in the pre-market session on Tuesday as...

Here is why Sanderson Farms Inc. (SAFM) stock rallied on Monday?

Sanderson Farms Inc. (SAFM) shares surged 10.16% in after-hours on Monday, June 21, 2021, and close the day at $183.50 per share. Earlier in...

Torchlight Energy Resources Inc. (TRCH) stock surged during current market trading. Here’s to know why?

Torchlight Energy Resources Inc. (NASDAQ: TRCH) stock gained by 41.33% in the current market trading session. Torchlight Energy Resources is a vast growing oil...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

We do not sell or share your information with anyone.

Get Notified Of Insider Trades, Analyst Upgrades & Downgrades, Earnings Updates & Best Stocks To Trade Every Single Morning

100% free. stop anytime no spam